FIRST AMENDMENT TO ADVISOR AGREEMENT
This FIRST AMENDMENT TO ADVISOR AGREEMENT is entered into effective as of January 1, 2026 (the “First Amendment Effective Date”) by and between MapLight Therapeutics, Inc., a Delaware corporation having a place of business at 800 Chesapeake Drive, Redwood City, CA 94063, and a successor in interest to Alvarado Therapeutics, Inc. (“Company”), and Robert Malenka (“Advisor”) (this “First Amendment”). Company and Advisor may be referred to herein individually as a “Party” and collectively as the “Parties.”
WHEREAS, Company and Advisor entered into that certain Advisor Agreement, effective February 25, 2019 (the “Agreement”), under which Company contracted with Advisor to provide Services in accordance with the terms thereto;
WHEREAS, Company and Advisor desire to amend the Agreement in accordance with the terms herein;
NOW THEREFORE, in consideration of the mutual covenants and promises set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:
“3. Consideration. Beginning on the First Amendment Effective Date, Advisor shall no longer receive monetary compensation in exchange for the provision of the Services. Notwithstanding the foregoing, Advisor shall be entitled to reimbursement for reasonable, documented expenses incurred in connection with his provision of the Services, provided that Advisor receives prior approval from Company.”
Signature Page to Follow



